ConvaTec Group (LON:CTEC) Insider Sells £681,288.66 in Stock

ConvaTec Group PLC (LON:CTEC) insider Jonny Mason sold 291,149 shares of the company’s stock in a transaction on Monday, March 16th. The shares were sold at an average price of GBX 234, for a total transaction of £681,288.66.

ConvaTec Group Stock Performance

Shares of LON CTEC traded up GBX 0.50 during mid-day trading on Tuesday, reaching GBX 234.30. 8,093,069 shares of the company were exchanged, compared to its average volume of 17,272,850. The company’s 50-day simple moving average is GBX 235.55 and its 200-day simple moving average is GBX 236.71. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 106.19. The stock has a market capitalization of £4.57 billion, a P/E ratio of 27.24, a P/E/G ratio of 0.93 and a beta of 0.76. ConvaTec Group PLC has a twelve month low of GBX 209.40 and a twelve month high of GBX 311.20.

Analyst Ratings Changes

Several brokerages have issued reports on CTEC. Stifel Nicolaus restated a “buy” rating and set a GBX 315 price objective on shares of ConvaTec Group in a research report on Wednesday, March 11th. Berenberg Bank upped their target price on ConvaTec Group from GBX 330 to GBX 340 and gave the company a “buy” rating in a research report on Thursday, January 22nd. Finally, Citigroup reiterated an “outperform” rating and set a GBX 315 target price on shares of ConvaTec Group in a research note on Thursday, March 5th. Eight equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of GBX 319.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.